Results 261 to 270 of about 390,088 (309)

Safety and Efficacy of a Treat-and-Extend Regimen of Anti-Vascular Endothelial Growth Factor Agents for Diabetic Macular Edema or Macular Edema Secondary to Retinal Vein Occlusion: A Systematic Review and Meta-Analysis.

Ophthalmic Surgery Lasers and Imaging Retina, 2023
[Box: see text] Background and Objective: This meta-analysis evaluates treat-and-extend regimens relative to monthly and as-needed (prn) regimens using anti-vascular endothelial growth factor agents for diabetic macular edema and macular edema secondary ...
Nikhil S. Patil, Arjan S. Dhoot, Prem A. H. Nichani, M. Popovic, R. Muni, P. Kertes   +5 more
semanticscholar   +1 more source

TREAT-AND-EXTEND REGIMEN WITH AFLIBERCEPT FOR RETINAL ANGIOMATOUS PROLIFERATION

Retina, 2016
To evaluate the effects of aflibercept therapy using a treat-and-extend regimen on treatment-naïve retinal angiomatous proliferation (RAP) and development of retinal pigment epithelium (RPE) atrophy.We retrospectively studied 17 treated eyes with RAP and 13 untreated fellow eyes.
Hidetaka, Matsumoto, Taku, Sato, Masahiro, Morimoto, Ryo, Mukai, Maki, Takahashi, Takashi, Hiroe, Kensuke, Ehara, Mayuko, Takayama, Kensuke, Mimura, Shoji, Kishi   +9 more
openaire   +2 more sources

Giant ancient schwannoma of pancreatic head treated by extended pancreatoduodenectomy

Pancreatology, 2004
We report a case of a 55-year-old woman who was transferred from another center to our university clinic after diagnostic laparotomy with a pancreatic head tumor which was seen to encase the portal vein. Although intraoperative biopsies were performed, a histologic diagnosis of the tumor was not possible before giving suspect to a malignant tumor being
Dobschütz, Ernst von, Walch, Axel Karl, Werner, Martin, Hopt, Ulrich T., Adam, Ulrich   +4 more
openaire   +3 more sources

Intravitreal ranibizumab versus aflibercept following treat and extend protocol for neovascular age-related macular degeneration

Graefe's Archive for Clinical and Experimental Ophthalmology, 2019
Alaadin Abdin, Achim Langenbucher, Berthold Seitz   +2 more
exaly   +2 more sources

The Cost-Effectiveness of Ranibizumab Treat and Extend Regimen Versus Aflibercept in the UK

Advances in Therapy, 2016
Wet age-related macular degeneration (AMD) is a chronic eye condition that causes severe deterioration of vision and even blindness. Current wet AMD treatment in the UK involves the vascular endothelial growth factor inhibitors ranibizumab and aflibercept.
Wrik, Ghosh, Rose, Wickstead, Lindsay, Claxton, Jeanette, Kusel, Matthew, Taylor, Kelly, Fleetwood, Ruth, Pulikottil-Jacob   +6 more
openaire   +2 more sources

Treat and extend versus PRN in diabetic retinopathy

Acta Ophthalmologica, 2016
SummaryVascular endothelial growth factor (VEGF) plays a key role in the pathogenesis of the neo‐vascular age related macular degeneration (nAMD) and the ischemic retinal microangiopathies. Targeting VEGF in retinal diseases became an effective therapeutic option.To optimize the benefit of risk ratio and cost effectiveness of anti‐VEGF agents, a number
openaire   +1 more source

Long-term outcome of treat and extend intravitreal ziv-aflibercept therapy

British Journal of Ophthalmology, 2018
AimTo assess the 30-month outcome of treat and extend (TAE) intravitreal ziv-aflibercept therapy in eyes with macular diseases.MethodsIn this prospective study, consecutive subjects received intravitreal 0.05 mL ziv-aflibercept (1.25 mg) injections for various macular diseases. Outcome measures were best-corrected visual acuity (BCVA) (logarithm of the
Ahmad M, Mansour, Abdulrazzak, Charbaji, Michel Eid, Farah, Hana A, Mansour, Jay, Chhablani   +4 more
openaire   +2 more sources

Treat-and-extend therapy with aflibercept for diabetic macular edema: a prospective clinical trial

Japanese Journal of Ophthalmology, 2021
To investigate the efficacy and safety of a treat-and-extend (T&E) regimen using aflibercept (Eylea) for diabetic macular edema (DME).Prospective, open-label, multicenter, single-arm, nonblinded clinical study.Forty eyes of 40 patients with DME received a T&E regimen of intravitreal aflibercept injection (IAI) with the longest treatment interval set to
Takao, Hirano, Yuichi, Toriyama, Yoshihiro, Takamura, Masahiko, Sugimoto, Taiji, Nagaoka, Yoshimi, Sugiura, Fumiki, Okamoto, Michiyuki, Saito, Kousuke, Noda, Shigeo, Yoshida, Akihiro, Ishibazawa, Osamu, Sawada, Toshinori, Murata   +12 more
openaire   +2 more sources

Hydrosalpinx treated with extended doxycycline does not compromise the success of in vitro fertilization

Fertility and Sterility, 2001
To determine if extended treatment with doxycycline before and after an in vitro fertilization (IVF) procedure can minimize the detrimental effect of a hydrosalpinx.Retrospective analysis.University IVF program.Patients undergoing IVF, including 17 with a hydrosalpinx, 25 with adhesions or proximal tubal occlusion, and 22 with endometriosis or ...
B S, Hurst, K E, Tucker, C A, Awoniyi, W D, Schlaff   +3 more
openaire   +2 more sources

Reactivation of stable neovascular age‐related macular degeneration following treat‐and‐extend regimen discontinuation

Clinical and Experimental Ophthalmology
To describe the incidence and pattern of reactivation of neovascular age‐related macular degeneration (nAMD) following successful treatment with treat‐and‐extend intravitreal anti‐vascular endothelial growth factor therapy.
J. C. M. Artiaga, S. Wong, Deepthy Menon, Swetha Kumar, P. Dhoble, Sridevi Thottarath, L. Nicholson   +6 more
semanticscholar   +1 more source